journal article·2011-06-06Open access

Contents: (Small 11/2011)

Authors not provided

Small· Volume 7· Issue 11

Abstract

Drug DeliveryThe cover picture shows magnetically doped mesoporous silica nanoparticles (MSNs) being fi rst internalized by a cell (top) and adsorbing intracellular molecules (green).The particles are then exocytosed from the cell.Afterwards the ejected particles are either retrieved with a magnet to harvest the sequestered proteins, or taken up by a neighboring cell, which, if cancerous, could be less prone to exocytose the MSNs.These results suggest that complex targeting groups might not be necessary in the use of nanoparticles to treat cancer, and they may open a new avenue for the use of nanoparticles as tools to harvest proteins and biomolecules from living cells.For more information, please read the Communication "Exocytosis of Mesoporous Silica Nanoparticles from Mammalian Cells: From Asymmetric Cell-to-Cell Transfer to Protein Harvesting" by I. I.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · AI and Big Data Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References

Reference metadata was not supplied for this record.